Dairy giant New Zealand endures butter price shock
The dairy price shock spreads as far as cheese and milk, leading one economist to suggest locals face the grim prospect of cereal without milk if they want to save money.
Butter prices leapt 46.5 percent in the year to June to an average of NZ$8.60 (US$5.09) for a 500-gram (1.1-pound) block, according to official data from Stats New Zealand.
Milk prices surged 14.3 percent over the same period, while cheese shot up 30 percent.
High dairy prices have hit the headlines in New Zealand, with media outlet Stuff reporting that 'exorbitant' prices are unlikely to 'melt away' any time soon.
Wholesale and retail store Costco restricted butter sales to a maximum of 30 blocks per customer in June, but still sold out, according to the New Zealand Herald.
The prices are hurting consumers, said independent economist Brad Olsen, chief executive of Infometrics.
'At the moment, I'm going with any other alternative I can find,' Olsen said of butter prices.
'I'd also say, the cheap option for breakfast at the moment seems to be to try cereal without the milk.'
The phenomenon was driven by international prices and demand, Olsen said.
Butter supplies had failed to keep up with rising demand over the past two years, he said.
'New Zealand exports the vast majority of our dairy products. So if you're a company that's exporting butter, you've got to make a decision. Do you sell it at the international price overseas, or do you sell it cheaper in New Zealand?' the economist said.
'No business is going to sell it cheaper… if they can get a better price overseas.'
But while New Zealand consumers were feeling the price pinch, the overall economy was benefiting as exporters creamed off larger profits from sales overseas.
'The sort of returns that our farmers and the primary sector more broadly are getting, and the economic benefit that brings, is actually far more substantial,' Olsen said.
'It's an extra NZ$4.6 billion (US$2.7 billion) that has been flowing into the economy from the higher dairy payout. That's a significant boost.'
New Zealand butter lovers are actually faring better than some, he said, adding they still pay 46 percent less than Americans. –AFP
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
an hour ago
- The Star
US not rushing trade deals ahead of August deadline, will talk with China: Bessent
WASHINGTON: The Trump administration is more concerned with the quality of trade agreements than their timing, US Treasury Secretary Scott Bessent (pic) said on Monday (July 21) ahead of an Aug 1 deadline for countries to secure trade deals or face steep tariffs. "We're not going to rush for the sake of doing deals," Bessent told CNBC. Asked whether the deadline could be extended for countries engaged in productive talks with Washington, Bessent said US President Donald Trump would decide. "We'll see what the president wants to do. But again, if we somehow boomerang back to the August 1 tariff, I would think that a higher tariff level will put more pressure on those countries to come with better agreements," he said. Trump has upended the global economy with a trade war that has targeted most US trading partners, but his administration has fallen far short of its plan to clinch deals with dozens of countries. Negotiations with India, the European Union, Japan, and others have proven more trying than expected. White House press secretary Karoline Leavitt told reporters Trump could discuss trade when he meets with Philippine President Ferdinand Marcos Jr at the White House on Tuesday. She said the Trump administration remained engaged with countries around the world and could announce more trade deals or send more letters notifying countries of the tariff rate they faced before Aug 1, but gave no details. Leavitt's comments came as European Union diplomats said they were exploring a broader set of possible counter-measures against the US, given fading prospects for an acceptable trade greement with Washington. An increasing number of EU members, including Germany, are now considering using "anti-coercion" measures that would let the bloc target US services or curb access to public tenders in the absence of a deal, diplomats said. "The negotiations over the level of tariffs are currently very intense," German Chancellor Friedrich Merz told a press conference. "The Americans are quite clearly not willing to agree to a symmetrical tariff arrangement." On China, Bessent said there would be "talks in the very near future." "I think trade is in a good place, and I think, now we can start talking about other things. The Chinese, unfortunately... are very large purchasers of sanctioned Iranian oil, sanctioned Russian oil," he said. "We could also discuss the elephant in the room, which is this great rebalancing that the Chinese need to do." US officials have long complained about China's overcapacity in various manufacturing sectors, including steel. Bessent told CNBC he would encourage Europe to follow the United States if it implements secondary tariffs on Russia. The Treasury chief, who returned from a visit to Japan on Sunday, said the administration was less concerned with the Asian country's domestic politics than with getting the best deal for Americans. Japan's chief tariff negotiator Ryosei Akazawa departed for trade talks in Washington on Monday morning, his eighth visit in three months, after the ruling coalition of Japanese Premier Shigeru Ishiba suffered a bruising defeat in upper house elections shaped in part by voter frustration over US tariffs. Indian trade negotiators returned to New Delhi after almost a week of talks in Washington, but officials were losing hope of signing an interim trade deal before the Aug 1 deadline, government sources said. - Reuters
Malaysian Reserve
3 hours ago
- Malaysian Reserve
Are parents ready to be the Bank of Mom and Dad?
YOUNG Americans are having trouble becoming fully independent adults. Millennials, who were long ridiculed for being boomerang kids who scurried back to mom and dad's basement after leaving the security blanket of college, know a thing or two about that. But the failure to launch trend is continuing with Gen Z, the latest cohort of 20-somethings taking out cash from the Bank of Mom and Dad. Over half of the adults in the generation reported that they don't pay for their own housing, according to a 2024 Bank of America (BOFA) study. In fact, parents of adult Gen Zers expect to give their children US$1,813 (RM7,703) a month in 2025, based on a March report by It's the highest level in three years and includes expenses for groceries, cell phones, rent and utility bills. This behaviour is not merely on account of arrested development. There are many factors at play, including the uncertainty around artificial intelligence (AI) and long-term employment prospects for entry-level jobs. It's a reality that raises a major question for current and prospective parents: Can you financially subsidise an adult child for the long-term? The cost of raising a child to 18 continues to rise and result in eye-watering predictions. Families spend an estimated average of US$26,000 annually on kids, which would equate to a total of US$468,000, according to recent analysis from SmartAsset. Those in high-cost-of-living areas or places with a scarcity issue for childcare pay even more. The average price tag of raising a child in Boston per year was estimated to be just under US$40,000 in 2025, for example. But this fixation on just getting a kid to 18 is such a narrow scope. According to Sallie Mae's annual 'How America Pays for College' report that analysed undergraduate data, parents helped their child pay for nearly 50% of college — a milestone that often lasts for more than the stereotypical four years — in 2024. Seven years ago, the company found that parents helped cover 31% of the cost. The average price of tuition and fees for a public four-year in-state college is US$11,610 for the 2024-2025 school year. Out-of-state schools cost nearly three times as much. Private nonprofit four-year colleges came with the highest price tag of US$43,350. After that life marker is passed, then the conversation of grad school — which costs an average of around US$43,000 a year — might come. While parents tend to cover this added expense less often, over the years articles, advice columns, social media posts and discussion boards have explored some version of this question: 'Should parents pay for graduate school too?' Whatever families' answers are, the expectation, at least, seems to be growing. And that's despite the fact that grad school itself may not be the answer to most young people's career woes. Keep in mind that this is what things cost currently. It's hard to imagine how much college will be for Gen Alpha. Looking at the last decade certainly doesn't paint an optimistic picture. The cost of a private nonprofit four-year degree was roughly US$13,000 more in the 2024-2025 school year than a decade prior. Approximately US$1,300 a year might not sound like much, but it represents a nearly 39% increase in a decade. The average public, four-year in-state school tuition has risen 27% over the same time period. Of course, generative AI could completely change the landscape of higher education before they get there. Trade and vocational schools could see increased enrolment as traditionally white-collar jobs lean more on technology. New grads are already at the forefront of seeing what it's like when a machine can take over entry-level (or higher) jobs. The unemployment rate for them hit 5.8% in March, which was a four-year high, according to the New York Federal Reserve (NY Fed). The other concern is underemployment, which is defined by the NY Fed as graduates working in jobs that typically do not require a college degree. A significant number of Gen Zers, 41.2%, are in this position. It's the making of the same conditions — recession woes and a tough job market post-The Great Recession — that kept millennial financially tethered to their parents well into adulthood and earned them criticism for draining their parents' retirement funds. Newer moms and dads might need to account for this. Americans believe they need US$1.26 million in order to retire comfortably, according to a 2025 Northwestern Mutual study. And yet, just over half think it is somewhat or very likely that they'll outlive their retirement savings, with 40% of boomers and 56% of Gen X reporting to have the concern. The gulf between what is needed to live a comfortable life and current retirement assets is wide. Boomers aged 61 to 79 have an average 401(k) balance of US$249,300 and average IRA (Individual Retirement Account) balance of US$257,002, based on Fidelity fourth quarter of 2024 data. Gen Xers have an average 401(k) balance of US$192,300 and an average IRA balance of US$103,592. Of course, members of both generations may be drawing down on their accounts already subsidising with Social Security or accessing pension funds in addition to these retirement accounts. It's a reminder that millennial and Gen Z parents of young children might need to structure their finances with long-term flexibility in mind. While the often-frustrating advice to 'figure it out as you go' holds some truth, too many moms and dads might be looking at their bundles of joy and rarely calculating the what ifs beyond the ages of 18 or 22. In reality, they should be bracing to keep the wallet open well into their child's adulthood, which may bring the possibility of delaying retirement. — Bloomberg This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners. This article first appeared in The Malaysian Reserve weekly print edition
New Straits Times
4 hours ago
- New Straits Times
AstraZeneca unveils US$50bil investment as pharma tariff threat looms
WASHINGTON: AstraZeneca plans to spend US$50 billion to expand manufacturing and research capabilities in the US by 2030, it said on Monday, the latest big investment by a pharmaceutical company reacting to President Donald Trump's tariff policy. The investment will fund a new drug manufacturing facility in Virginia and expand research and development (R&D) and cell therapy manufacturing in Maryland, Massachusetts, California, Indiana and Texas, it said in a statement. It will also upgrade the Anglo-Swedish drugmaker's US clinical trial supply network and support ongoing investment in novel medicines. On Monday, AstraZeneca said the expansion supports its ambition to reach US$80 billion in annual revenue by 2030, with half coming from the US. The US accounted for more than 40 per cent of AstraZeneca's annual revenue in 2024, and the company had been prioritising the market – the world's largest, worth US$635 billion – before Trump's return to office. The move to scale up its US footprint is the latest by a drugmaker as Trump threatens to impose import tariffs on the industry and seeks to boost domestic manufacturing. The sector has historically been spared from trade disputes. Trump has called on pharma companies to make more of the medicines they sell in the US within the country, rather than importing active ingredients or finished medicines. He is also pushing for prices in the US to fall to what other countries pay. CEO Pascal Soriot announced the plans in Washington, saying he believes that drug prices need to rise elsewhere and "equalise" with other countries effectively contributing more to research and development costs. "The United States cannot build or carry the cost of R&D for the entire world," he said. US Commerce Secretary Howard Lutnick's department is leading a probe into pharmaceutical imports that could pave the way for new tariffs. "For decades Americans have been reliant on foreign supply of key pharmaceutical products. President Trump and our nation's new tariff policies are focused on ending this structural weakness," said Lutnick in a statement issued by AstraZeneca. While Trump has repeatedly threatened tariffs on the sector, he signalled earlier this month that companies would be given a year to 18 months to "get their act together" before any levies take effect. The company said that the timing and location of the announcement was linked to the US policy environment, though some of the spending would have occurred regardless so that the infrastructure for future medicines was in place. The pledge is in addition to the US$3.5 billion in investments the company announced in November 2024, the statement said. Pledges The US$50 billion pledge matches the commitment announced by Swiss rival Roche in April and follows new spending plans unveiled this year by Eli Lilly & Co, Johnson & Johnson, Novartis, and Sanofi. Also present at the announcement was Virginia State Governor Glenn Youngkin, a vocal Trump ally who has defended the administration's tariff policies. The new Virginia facility – the company's largest single manufacturing investment – will produce active ingredients for AstraZeneca's experimental weight-loss medicines, including its oral GLP-1 candidate and an oral PCSK9 inhibitor for cholesterol management, it said. The company said the investment could create tens of thousands of new jobs, but declined to give specifics. It employs about 18,000 people in the US and has a global workforce of about 90,000. In January, it scrapped plans to invest £450 million (US$607.10 million) in its vaccine manufacturing plant in northern England, citing a cut in government support. Earlier this month, The Times reported the company was considering moving its stock market listing from London – where it is the exchange's most valuable company worth £159 billion – to the US. The company declined to comment.
